Cargando…
Approaching the challenges of MKK3/p38delta MAPK targeting for therapeutic purpose in colorectal cancer
MKK3 is a member of the dual specificity kinase group specific upstream activator of p38 MAPK proteins. We originally identified MKK3 as mutant p53 (mutp53) gain-of-function (GOF) upregulated target gene in different tumor models. To deeply investigate the MKK3 functions in cancer, taking advantage...
Autores principales: | Stramucci, Lorenzo, Bossi, Gianluca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6935053/ https://www.ncbi.nlm.nih.gov/pubmed/31881903 http://dx.doi.org/10.1186/s13046-019-1513-4 |
Ejemplares similares
-
Insights of Crosstalk between p53 Protein and the MKK3/MKK6/p38 MAPK Signaling Pathway in Cancer
por: Stramucci, Lorenzo, et al.
Publicado: (2018) -
MKK3 sustains cell proliferation and survival through p38DELTA MAPK activation in colorectal cancer
por: Stramucci, Lorenzo, et al.
Publicado: (2019) -
The p38 MAPK Signaling Activation in Colorectal Cancer upon Therapeutic Treatments
por: Pranteda, Angelina, et al.
Publicado: (2020) -
Anti-oncogenic and pro-myogenic action of the MKK6/p38/AKT axis induced by targeting MEK/ERK in embryonal rhabdomyosarcoma
por: Di Rocco, Agnese, et al.
Publicado: (2022) -
Balance between MKK6 and MKK3 Mediates p38 MAPK Associated Resistance to Cisplatin in NSCLC
por: Galan-Moya, Eva M., et al.
Publicado: (2011)